Wenhong Deng
-
- Cancer Immunotherapy and Biomarkers 6
- Inflammatory Biomarkers in Disease Prognosis 4
- Pancreatic and Hepatic Oncology Research 2
-
- Cancer, Lipids, and Metabolism 5
- Cancer, Hypoxia, and Metabolism 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- RNA modifications and cancer 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
- Co-authors
- Weixing WangLilong ZhangChunlei LiZhendong QiuTianrui KuangChen ChenLi LiuKeshuai Dong
- Cited by
- OncologyCancer ResearchHepatology
- Journals
- Scientific Reports (2 papers)Frontiers in Immunology (2 papers)Frontiers in Microbiology (2 papers)
- Partner nations
- China
In The Last Decade
Wenhong Deng
20 papers receiving 297 citations
Peers
Comparison fields: 5 of 70
- Oncology 124
- Cancer Research 67
- Hepatology 30
- Molecular Biology 125
- Pulmonary and Respiratory Medicine 57
Countries citing papers authored by Wenhong Deng
This map shows the geographic impact of Wenhong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhong Deng more than expected).
Fields of papers citing papers by Wenhong Deng
This network shows the impact of papers produced by Wenhong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhong Deng. The network helps show where Wenhong Deng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenhong Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 43 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 37 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 13 | |
| 16 | 2022 | 15 | |
| 17 | 2022 | 6 | |
| 18 | 2022 | 25 | |
| 19 | 2022 | 31 | |
| 20 | 2022 | 6 |
About Wenhong Deng
Wenhong Deng is a scholar working on Oncology, Hepatology and Cancer Research, having authored 21 papers that have together received 298 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer, Lipids, and Metabolism (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Oncology (124 citations), Cancer Research (67 citations) and Hepatology (30 citations). Wenhong Deng has collaborated with scholars based in China. Frequent co-authors include Weixing Wang, Lilong Zhang, Chunlei Li, Zhendong Qiu, Tianrui Kuang, Chen Chen, Li Liu, Keshuai Dong, Yongjun Guan and Li Liu. Their work appears in journals such as Scientific Reports, Frontiers in Immunology and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.